Global Peptide Therapeutics Market Status and Outlook 2018-2025

August 2018 | 156 pages | ID: G22B8C69FEFEN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Sanofi
• Teva
• Novo Nordisk
• Takeda
• Eli Lilly
• AstraZeneca
• Novartis
• Shire
• AbbVie
• Ipsen
• Allergan
• Ferring
• Merck
• The Medicines
• Roche
• J & J

Market by Type

• Injection
• Oral
• Other

Market by Application

• Cancer
• Metabolic Disorders
• Central Nervous System
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Peptide Therapeutics Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Injection
  3.1.2 Oral
  3.1.3 Other
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Cancer
  4.1.2 Metabolic Disorders
  4.1.3 Central Nervous System
  4.1.4 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Injection Production by Region
    6.1.1.2 Oral Production by Region
    6.1.1.3 Other Production by Region
  6.1.2 Production by Application
    6.1.2.1 Cancer Production by Region
    6.1.2.2 Metabolic Disorders Production by Region
    6.1.2.3 Central Nervous System Production by Region
    6.1.2.4 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Injection Demand by Region
    6.2.1.2 Oral Demand by Region
    6.2.1.3 Other Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Cancer Demand by Region
    6.2.2.2 Metabolic Disorders Demand by Region
    6.2.2.3 Central Nervous System Demand by Region
    6.2.2.4 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Sanofi
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Teva
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Novo Nordisk
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Takeda
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Eli Lilly
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 AstraZeneca
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Novartis
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Shire
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 AbbVie
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Ipsen
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Allergan
8.12 Ferring
8.13 Merck
8.14 The Medicines
8.15 Roche
8.16 J & J

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Peptide Therapeutics Industry Dynamics & Regulations List
Table Global Peptide Therapeutics Sales Revenue, Cost and Margin, 2015-2018E
Table Global Peptide Therapeutics Market Status by Type 2015-2018E, in USD Million
Table Global Peptide Therapeutics Market Status by Application 2015-2018E, in USD Million
Table Global Peptide Therapeutics Market Status by Application 2015-2018E, in Volume
Table Global Peptide Therapeutics Market by Region 2015-2018E, in USD Million
Table Global Peptide Therapeutics Market Share by Region in 2018, in USD Million
Table Global Peptide Therapeutics Market by Region 2015-2018E, in Volume
Table Global Peptide Therapeutics Market Share by Region in 2018, in Volume
Table Injection Production Value by Region 2015-2018E, in USD Million
Table Injection Production Volume by Region 2015-2018E, in Volume
Table Oral Production Value by Region 2015-2018E, in USD Million
Table Oral Production Volume by Region 2015-2018E, in Volume
Table Other Production Value by Region 2015-2018E, in USD Million
Table Other Production Volume by Region 2015-2018E, in Volume
Table Cancer Production Value by Region 2015-2018E, in USD Million
Table Cancer Production Volume by Region 2015-2018E, in Volume
Table Metabolic Disorders Production Value by Region 2015-2018E, in USD Million
Table Metabolic Disorders Production Volume by Region 2015-2018E, in Volume
Table Central Nervous System Production Value by Region 2015-2018E, in USD Million
Table Central Nervous System Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Injection Market Size by Region 2015-2018E, in USD Million
Table Injection Market Size by Region 2015-2018E, in Volume
Table Oral Market Size by Region 2015-2018E, in USD Million
Table Oral Market Size by Region 2015-2018E, in Volume
Table Other Market Size by Region 2015-2018E, in USD Million
Table Other Market Size by Region 2015-2018E, in Volume
Table Cancer Market Size by Region 2015-2018E, in USD Million
Table Cancer Market Size by Region 2015-2018E, in Volume
Table Metabolic Disorders Market Size by Region 2015-2018E, in USD Million
Table Metabolic Disorders Market Size by Region 2015-2018E, in Volume
Table Central Nervous System Market Size by Region 2015-2018E, in USD Million
Table Central Nervous System Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalPeptide Therapeutics Forecast by Type 2019F-2025F, in USD Million
Table Peptide Therapeutics Forecast by Type 2019F-2025F, in Volume
Table Peptide Therapeutics Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Peptide Therapeutics Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Peptide Therapeutics Market Forecast by Region 2019F-2025F, in USD Million
Table Peptide Therapeutics Market Forecast by Region 2019F-2025F, in Volume
Table Sanofi Information
Table Peptide Therapeutics Sales, Cost, Margin of Sanofi
Table Teva Information
Table Peptide Therapeutics Sales, Cost, Margin of Teva
Table Novo Nordisk Information
Table Peptide Therapeutics Sales, Cost, Margin of Novo Nordisk
Table Takeda Information
Table Peptide Therapeutics Sales, Cost, Margin of Takeda
Table Eli Lilly Information
Table Peptide Therapeutics Sales, Cost, Margin of Eli Lilly
Table AstraZeneca Information
Table Peptide Therapeutics Sales, Cost, Margin of AstraZeneca
Table Novartis Information
Table Peptide Therapeutics Sales, Cost, Margin of Novartis
Table Shire Information
Table Peptide Therapeutics Sales, Cost, Margin of Shire
Table AbbVie Information
Table Peptide Therapeutics Sales, Cost, Margin of AbbVie
Table Ipsen Information
Table Peptide Therapeutics Sales, Cost, Margin of Ipsen
Table Allergan Information
Table Peptide Therapeutics Sales, Cost, Margin of Allergan
Table Ferring Information
Table Peptide Therapeutics Sales, Cost, Margin of Ferring
Table Merck Information
Table Peptide Therapeutics Sales, Cost, Margin of Merck
Table The Medicines Information
Table Peptide Therapeutics Sales, Cost, Margin of The Medicines
Table Roche Information
Table Peptide Therapeutics Sales, Cost, Margin of Roche
Table J & J Information
Table Peptide Therapeutics Sales, Cost, Margin of J & J
Table Global Peptide Therapeutics Sales Revenue by Company 2015-2017, in USD Million
Table Global Peptide Therapeutics Sales Volume by Company 2015-2017, in Volume
Table Global Peptide Therapeutics Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Peptide Therapeutics Picture
Figure Peptide Therapeutics Industry Chain Diagram
Figure Global Peptide Therapeutics Sales Revenue 2015-2018E, in USD Million
Figure Global Peptide Therapeutics Sales Volume 2015-2018E, in Volume
Figure Global Peptide Therapeutics Market Status by Type 2015-2018E, in Volume
Figure North America Peptide Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure North America Peptide Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Europe Peptide Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure Europe Peptide Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Peptide Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Peptide Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure South America Peptide Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure South America Peptide Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Middle East Peptide Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Peptide Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Africa Peptide Therapeutics Market Size and Growth 2015-2018E, in USD Million
Figure Africa Peptide Therapeutics Market Size and Growth 2015-2018E, in Volume
Figure Global Peptide Therapeutics Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Peptide Therapeutics Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Peptide Therapeutics Sales Price Forecast 2019F-2025F
Figure Global Peptide Therapeutics Gross Margin Forecast 2019F-2025F
Figure Global Peptide Therapeutics Sales Revenue by Company in 2018, in USD Million
Figure Global Peptide Therapeutics Price by Company in 2018
Figure Global Peptide Therapeutics Gross Margin by Company in 2018